Incorporation of oleic acid and eicosapentaenoic acid into glycerolipids of cultured normal human fibroblasts
Abstract
Confluent skin fibroblasts from normal humans were incubated in serum free medium with up to 100 nmole/mL eicosapentaenoic acid (EPA; bound to albumin in a 4.6:1 ratio) and compared with cells incubated with oleic acid (OA) at similar concentrations. The rate of [14C]OA incorporation into triacylglycerol (TG) (nmol/mg/h) was approximately 5-fold greater than that of [14C]EPA. The mass of TG formed after incubation of fibroblasts with EPA was also significantly lower than that formed with OA (43.2 +/- 9.3 vs. 59.5 +/- 6.6 micrograms/mg cell protein, respectively, P = 0.006). The addition of excess, unlabeled EPA reduced the rate of incorporation of [14C]OA into TG whereas unlabeled OA stimulated incorporation of [14C]EPA into TG. When the cells were preincubated with human serum basic proteins (BP I, II and III), the mass of TG formed (compared to baseline) was significantly higher with the basic proteins whether OA or EPA was studied. Only BP I significantly stimulated the mass of cell phospholipids, an effect that occurred with either OA or EPA in the medium. The results suggest that in cultured normal human fibroblasts, OA is a better substrate for TG synthesis than EPA and that this effect may be accentuated by the presence of the basis proteins.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EPA reduces de novo lipogenesis by inhibiting transcription of the gene for SREBP-1c.
“Furthermore, EPA reduces de novo lipogenesis by inhibiting transcription of the gene for SREBP (sterol regulatory element binding protein)-1c.85”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [85]
Cited by
Sorted by citations
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
Harris, W. S., Miller, M., Tighe, A. P., Davidson, M. H., & Schaefer, E. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.008 · Cited by 552 · see citing works
Self-citationSkulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 488 · see citing works
Self-citationControversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis
Quispe, R., Alfaddagh, A., Kazzi, B., Zghyer, F., Marvel, F. A., Blumenthal, R. S., Sharma, G., & Martin, S. S. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01031-9 · Cited by 17 · see citing works
- Authors
- Miller, M., Motevalli, M., Westphal, D., & Kwiterovich, P. O.
- Affiliations
- University of Maryland Medical Center (US)
- University of Maryland Medical System (US)
- ORCID
- Miller, Michael
- Venue
- Lipids
- Publisher
- Wiley
- Published
- 1993-01
- Volume
- 28
- Issue
- 1
- Pages
- 1-5
- ISSN
- 0024-4201 (ISSN-L)
- 1558-9307
- OpenAlex
- W2056822686
- Cited by
- 17
- References
- 0
- Citations by year
- 2024: 1 · 2022: 1 · 2019: 2 · 2017: 1 · 2013: 1
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lipids (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k07hl001113-03, 5p50hl047212-04, 5r01hl031497-06)
- National Heart, Lung, and Blood Institute (HL31497, HL-47212, 5K07HL01113)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- oleic acid, eicosapentaenoic acid, triglyceride synthesis, glycerolipids, human dermal fibroblasts, fatty acid incorporation, phospholipid synthesis
- MeSH terms
- Binding, Competitive, Blood Proteins, Cells, Cultured, Fibroblasts, Humans, Lipids, Oleic Acids, Triglycerides, Eicosapentaenoic Acid, Oleic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review